Table of Contents
<< Previous Issue | Jan 2019 (Vol: 2019, Issue: 1) | Next Issue >> |
- Section: Licensing
-
Codiak Biosciences’ Exosome Therapeutics Attracts Jazz Pharmaceuticals
- Section: Mergers & Acquisitions
-
BMS Latest to Quit Consumer Health with UPSA Divestment
-
BMS Acquires Celgene in First Major Deal of 2019
-
Lilly Bolsters Oncology Pipeline with US$8 B Takeover of Loxo Oncology
-
Acrotech Biopharma to Enhance US Presence with Spectrum Pharmaceuticals
- Section: Opinion & Analysis
-
Deal Trends in Immuno-Oncology
- Section: Research & Development
-
Gilead Signs US$1.53 B Deal with Scholar Rock to Strengthen its Fibrotic Diseases Pipeline
-
Biogen Bolsters Neurology Pipeline with C4 Therapeutics and Skyhawk Deals
-
Genentech Pushes for Leadership in Cancer Diagnostics with Adaptive Biotechnologies Deal